Shortage pharmaceuticals

Ended Awarded Last action

Contract number
0014
Awardee
Awarding agency
Obligated
$292,689

Award facts

Contract value 100% obligated
$292,688.55 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 · DE-obligate funds - shortage pharmaceuticals -$7,311
Other Administrative Action 1 $0
Original award $300,000

About this award

The U.S. government's Defense Health Agency (DHA) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract worth $292,688.55 to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals. The contract has an ultimate completion date of September 30, 2016. This contract is under a larger $2 million BPA awarded to TDS Med, Inc. by DHA in September 2019 to provide pharmaceutical products and supplies, including blood products, orals, injectables and medical inhalations, to address shortages. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 0014?

0014 was awarded to TDS Med, Inc. by Defense Health Agency (Department of Defense) on May 17, 2016.

How much is contract 0014 worth?

The government has obligated $292,689 on 0014.

Is contract 0014 an order under another contract?

Yes. 0014 is a BPA call under HT001414A0004, a blanket purchase agreement.

Was contract 0014 competed?

The extent of competition for 0014 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award